NDC Product
Human Prescription DrugDexlansoprazole NDC 0378-2085
- Generic Name
- Dexlansoprazole
- Dosage Form
- Capsule, Delayed Release Pellets
- Route
- Oral
- Marketing
- ANDA
Active Listing
This profile provides standardized clinical and technical data for Dexlansoprazole Sesquihydrate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) HS2S9VK3NH.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 313640-86-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
2C16H14F3N3O2S.3H2O XTQWZVSRVXCIGB-BBBDYAHLSA-N This section provides a complete list of nomenclature and identifier mappings for Dexlansoprazole Sesquihydrate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.
This unique ingredient identifier is listed as an ingredient or substance in the following products in the NDC directory: